Abstract
Renal cancer accounts for more than 90 % of all renal tumours. Men are more at risk than females with incidence increasing with age. The exact cause for RCC is unknown but several risk factors have important significance. Tobacco smoking, obesity, hypertension, lack of physical activity and occupational factors have been implicated as risk factors. Kidney cancer is now known to be a genetic disease made up of a number of different cancers each with their own histology, genetic alteration, clinical course and response to therapy. Benign kidney tumours include angiomyolipoma, papilloma and oncocytoma.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.
Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765–81.
Levi F, Ferlay J, Galeone C, et al. The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int. 2008;101:949–58.
Chow WH, Devesa SS. Contemporary epidemiology of renal cell cancer. Cancer J. 2008;14:288–301.
Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579–91.
Hunt JD, van der Hel OL, McMillan GP, et al. Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer. 2005;114:101–8.
Kroeger N, Klatte T, Birkhäuser FD, et al. Smoking negatively impacts renal cell carcinoma overall and cancer-specific survival. Cancer. 2012;118:1795–802.
Gago-Dominguez M, Castelao JE, Yuan JM, et al. Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma. Cancer Causes Control. 2002;13:287–93.
Adams KF, Leitzmann MF, Albanes D, et al. Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol. 2008;168:268–77.
Colt JS, Schwartz K, Graubard BI, et al. Hypertension and risk of renal cell carcinoma among white and black Americans. Epidemiology. 2011;22:797–804.
Weikert S, Boeing H, Pischon T, et al. Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. Am J Epidemiol. 2008;167:438–46.
Fryzek JP, Poulsen AH, Johnsen SP, et al. A cohort study of antihypertensive treatments and risk of renal cell cancer. Br J Cancer. 2005;92:1302–6.
Chow WH, Gridley G, Fraumeni Jr JF, Järvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med. 2000;343(18):1305–11.
Lee JE, Spiegelman D, Hunter DJ, Albanes D, Bernstein L, et al. Fat, protein, and meat consumption and renal cell cancer risk: a pooled analysis of 13 prospective studies. J Natl Cancer Inst. 2008;100(23):1695–706.
Wolk A, Linbald P, Adami HO. Nutrition and renal cell cancer. Cancer Causes Control. 1996;7:5–18.
Lew JQ, Chow WH, Hollenbeck AR, Schatzkin A, Park Y. Alcohol consumption and risk of renal cell cancer: the NIH-AARP diet and health study. Br J Cancer. 2011;104(3):537–41.
Moore LE, Boffetta P, Karami S, et al. Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants. Cancer Res. 2010;70:6527–36.
Boffetta P, Fontana L, Stewart P, et al. Occupational exposure to arsenic, cadmium, chromium, lead and nickel, and renal cell carcinoma: a case–control study from Central and Eastern Europe. Occup Environ Med. 2011;68:723–8.
Cho E, Curhan G, Hankinson SE, et al. Prospective evaluation of analgesic use and risk of renal cell cancer. Arch Intern Med. 2011;171:1487–93.
Marple JT, MacDougall M, Chonko AM. Renal cancer complicating acquired cystic kidney disease. J Am Soc Nephrol. 1994;4:1951–6.
Cairns P. Renal cell carcinoma. Cancer Biomark. 2011;9:461–73.
Kato M, Suzuki T, Suzuki Y, et al. Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J Urol. 2004;172:863–6.
Frank I, Blute ML, Cheville JC, et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170:2217–20.
Lamb GW, Bromwich EJ, Vasey P, Aitchison M. Management of renal masses in patients medically unsuitable for nephrectomy-natural history, complications and outcome. Urology. 2004;64:909–13.
Linehan WM. Molecular targeting of VHL gene pathway in clear cell kidney cancer. J Urol. 2003;170:593–4.
Randi G, Pelucchi C, Negri E, et al. Family history of urogenital cancers in patients with bladder, renal cell and prostate cancers. Int J Cancer. 2007;121:2748–52.
Czene K, Hemminki K. Kidney cancer in the Swedish Family Cancer Database: familial risks and second primary malignancies. Kidney Int. 2002;61:1806–13.
Knudson AG. Genetics of human cancer. J Cell Physiol Suppl. 1986;4:7–11.
Dalgliesh GL, Furge K, Greenman C, Chen L, et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature. 2010;463:360–3.
Semenza GL. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology. 2004;19:176–82.
Nordstrom-O’Brien M, van der Luijt RB, van Rooijen E, et al. Genetic analysis of von Hippel-Lindau disease. Hum Mutat. 2010;31:521–37.
Kim E. Mechanisms of amino acid sensing in mTOR signaling pathway. Nutr Res Pract. 2009;3:64–71.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag London
About this chapter
Cite this chapter
Alleemudder, A., Seth, A., Nargund, V.H. (2015). Renal Cancer – Epidemiology and Aetiology. In: Nargund, V., Raghavan, D., Sandler, H. (eds) Urological Oncology. Springer, London. https://doi.org/10.1007/978-0-85729-482-1_18
Download citation
DOI: https://doi.org/10.1007/978-0-85729-482-1_18
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-481-4
Online ISBN: 978-0-85729-482-1
eBook Packages: MedicineMedicine (R0)